Yingzhe Wang

5PUBLICATIONS
48CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMajor global burdens of diseaseMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 25, 2024
Group 3 medulloblastoma transcriptional networks collapse under domain specific EP300/CBP inhibition.

Noha A M Shendy, Melissa Bikowitz, Logan H Sigua

|Jun 21, 2023
Efficacy of oseltamivir treatment in influenza virus-infected obese mice.

Rebekah Honce, Jeremy Jones, Victoria A Meliopoulos

|Nov 01, 2022
Combination of Ribociclib with BET-Bromodomain and PI3K/mTOR Inhibitors for Medulloblastoma Treatment In Vitro and In Vivo.

Barbara Jonchere, Justin Williams, Frederique Zindy

|Nov 10, 2021
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma.

Min Pan, William C Wright, Richard H Chapple

Pageof 1